Showing results (731-740 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|September 17, 2016
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysisAdel Shahnam, Zainab Ridha, Michael D Wiese, et al.
Pharmacogenomics|June 9, 2017
The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitalsMarc Hinderer, Martin Boeker, Sebastian A Wagner, et al.
Pharmacogenomics|June 9, 2017
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approachWei Chuen Tan-Koi, Cynthia Sung, Yong Yeow Chong, et al.
Pharmacogenomics|June 9, 2017
Pharmacogenomics in Asia: a systematic review on current trends and novel discoveriesHazel Xiaohui Ang, Sze Ling Chan, Levana L Sani, et al.
Pharmacogenomics|June 15, 2017
Methods to analyze big data in pharmacogenomics researchRuowang Li, Dokyoon Kim, Marylyn D Ritchie
Pharmacogenomics|June 9, 2017
Genetic variants associated with warfarin dosage in Kuwaiti populationSumi Elsa John, Dinu Antony, Muthukrishnan Eaaswarkhanth, et al.
Pharmacogenomics|June 9, 2017
Influence of two variants of CYP450 oxidoreductase on the stable dose of acenocoumarol in a Spanish populationHoi Y Tong, Alberto M Borobia, José Carlos Martínez Ávila, et al.
Pharmacogenomics|June 23, 2017
MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapyKarin Vos, Carlotta Lo Sciuto, Rita Piedade, et al.
Pharmacogenomics|October 25, 2021
Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and IndonesiaAnar Sanjaykumar Kothary, Caroline Mahendra, Mingchen Tan, et al.
Pharmacogenomics|October 19, 2021
Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN studyNavin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, et al.
Pageof 274